Search

Author/Creator Mileshkin, Linda

61. Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series. (December 2018)

Authors:
Mitchell, Emma L.; Lau, Peter Kar Han; Khoo, Chloe; Liew, David; Leung, Jessica; Liu, Bonnia; Rischin, Adam; Frauman, Albert G.; Kee, Damien; Smith, Kortnye; Brady, Benjamin; Rischin, Danny; Gibson, Andrew; Mileshkin, Linda; Klein, Oliver; Weickhardt, Andrew; Arulananda, Surein; Shackleton, Mark;...
Journal:
European journal of cancer
Issue:
Volume 105(2018)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

62. Smokers With Cervix Cancer Have More Uterine Corpus Invasive Disease and an Increased Risk of Recurrence After Treatment With Chemoradiation. Issue 7 (1st September 2014)

Authors:
Mileshkin, Linda; Paramanathan, Ashvin; Kondalsamy-Chennakesavan, Srinivas; Bernshaw, David; Khaw, Pearly; Narayan, Kailash
Journal:
International journal of gynecological cancer
Issue:
Volume 24:Issue 7(2014)
Page Start:
1286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

63. Supporting cancer care clinicians to 'hold' their patients during and beyond the COVID‐19 pandemic: a role for reflective ethics discussions. Issue 7 (18th July 2021)

Authors:
Delany, Clare; Benhamu, Joanne; McDougall, Rosalind; Ko, Danielle; Jones, Hayley; Mileshkin, Linda; Largey, Geraldine; Clinch, Alex; Heynemann, Sarah
Journal:
Internal medicine journal
Issue:
Volume 51:Issue 7(2021)
Page Start:
1143
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

64. Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia. Issue 8 (August 2017)

Authors:
Lee, Yeh Chen; Kroon, René; Koczwara, Bogda; Haines, Ian; Francis, Kay; Millward, Michael; Kefford, Richard; Olver, Ian; Mileshkin, Linda
Journal:
Internal medicine journal
Issue:
Volume 47:Issue 8(2017)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

65. Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non‐small‐cell lung carcinoma. Issue 1 (3rd January 2018)

Authors:
Tan, Lavinia; Alexander, Marliese; Officer, Ann; MacManus, Michael; Mileshkin, Linda; Jennens, Ross; Herath, Dishan; de Boer, Richard; Fox, Stephen B; Ball, David; Solomon, Benjamin
Journal:
Internal medicine journal
Issue:
Volume 48:Issue 1(2018)
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

67. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial. Issue 8 (August 2016)

Authors:
de Boer, Stephanie M; Powell, Melanie E; Mileshkin, Linda; Katsaros, Dionyssios; Bessette, Paul; Haie-Meder, Christine; Ottevanger, Petronella B; Ledermann, Jonathan A; Khaw, Pearly; Colombo, Alessandro; Fyles, Anthony; Baron, Marie-Helene; Kitchener, Henry C; Nijman, Hans W; Kruitwagen, Roy F; N...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 8(2016:Aug.)
Page Start:
1114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

68. Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients. Issue 7 (23rd March 2022)

Authors:
Sivakumaran, Tharani; Krasovitsky, Michael; Freimund, Alison; Lee, Yeh Chen; Webber, Kate; So, Jane; Norris, Christie; Friedlander, Michael; Mileshkin, Linda; Au-Yeung, George
Journal:
International journal of gynecological cancer
Issue:
Volume 32:Issue 7(2022)
Page Start:
906
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗